CV Sciences (CVSI) Retained Earnings (2011 - 2026)
CV Sciences (CVSI) reported Retained Earnings of $32000.0 for Q1 2026, up 146.15% on a YoY basis from $13000.0 in Q1 2025, and down 99.96% sequentially from $89.3 million in Q4 2025.
CV Sciences (CVSI) Retained Earnings (2011 - 2026) Analysis & Trends
CV Sciences (CVSI) has 16 years of Retained Earnings data on file, last reported at $32000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 146.15% year-over-year to $32000.0; the trailing twelve-month figure through Mar 2026 stood at $32000.0 (up 146.15% YoY), and the FY2025 full-year result was $89.3 million, up 595633.33% from the prior year.
- Retained Earnings declined to $32000.0 in Q1 2026, from $89.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $89.3 million in Q4 2025 to a low of -$87.4 million in Q2 2025.
- A 5-year average of $1.6 million and a median of $5500.0 in 2024 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 595633.33% in 2025, while the deepest fall reached 4369900.0% in 2025.
- Tracing CVSI's Retained Earnings over 5 years: stood at $86.7 million in 2022, then slumped by 197.53% to -$84.6 million in 2023, then surged by 99.98% to -$15000.0 in 2024, then soared by 595633.33% to $89.3 million in 2025, then tumbled by 99.96% to $32000.0 in 2026.
- Business Quant data shows CVSI's Retained Earnings at $32000.0 in Q1 2026, $89.3 million in Q4 2025, and $89.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | 32,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32,000.00 |
| Dec 31, 2025 | 89.33 Mn |
| Sep 30, 2025 | 89.21 Mn |
| Jun 30, 2025 | -87.40 Mn |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Sep 30, 2024 | 88.41 Mn |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | 87.56 Mn |
| Dec 31, 2023 | -84.59 Mn |
| Sep 30, 2023 | 87.18 Mn |
| Jun 30, 2023 | -83.30 Mn |
| Mar 31, 2023 | -81.98 Mn |
| Sep 30, 2022 | 86.73 Mn |
| Jun 30, 2022 | -84.30 Mn |
| Mar 31, 2022 | -81.70 Mn |
| Dec 31, 2021 | 83.01 Mn |
| Sep 30, 2021 | -70.62 Mn |
| Jun 30, 2021 | 80.54 Mn |
| Mar 31, 2021 | -67.05 Mn |